Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 11/20 | 1.00 |
| ▸ | PDE1A | P54750 | 5/20 | 0.75 |
| ▸ | PDE1B | Q01064 | 5/20 | 0.75 |
| ▸ | PDE1C | Q14123 | 5/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.75 |
| ▸ | MEN1 | O00255 | 1/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.75 |
| ▸ | HPGD | P15428 | 1/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.75 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.59 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.59 |
| ▸ | GUSB | P08236 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12462404 | 0.88 | PDE5A (0.84) | PDE5APDE1APDE1BPDE1CKDM4E | |
| SCHEMBL5230167 | 0.87 | PDE5A (0.77) | PDE5APDE1APDE1BPDE1CKDM4E | |
| SCHEMBL31174349 | 0.86 | PDE5A (1.00) | PDE5APDE1APDE1BPDE1CKDM4E | |
| SCHEMBL1202 | 0.86 | PDE5A (1.00) | PDE5APDE1APDE1BPDE1CKDM4E | |
| SCHEMBL1751 | 0.85 | PDE5A (0.83) | PDE5APDE1APDE1BPDE1CKDM4E | |
| SCHEMBL12341662 | 0.82 | PDE5A (0.69) | PDE5APDE1APDE1BPDE1CKDM4E | |
| SCHEMBL5230160 | 0.81 | PDE5A (0.68) | PDE5APDE1APDE1BPDE1CKDM4E | |
| SCHEMBL845 | 0.81 | PDE5A (0.68) | PDE5APDE1APDE1BPDE1CKDM4E | |
| SCHEMBL6330165 | 0.79 | PDE5A (0.65) | PDE5APDE1APDE1BPDE1CKDM4E | |
| SCHEMBL6642645 | 0.78 | PDE5A (0.67) | PDE5APDE1APDE1BPDE1CKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1759700-A1 | Use of a PDE5 inhibitor for treating and preventing hypopigmentary disorders | Switch Biotech Aktiengesellschaft (DE) | 2007-03-07 | — | — | EP | disclosed |
| WO-2006018088-A1 | USE OF A PDE 5 INHIBITOR FOR TREATING AND PREVENTING HYPOPIGMENTARY DISORDERS | SWITCH BIOTECH AG (DE) | 2006-02-23 | — | — | WO | disclosed |
| US-6200980-B1 | ADMINISTERING PHENYL PURINONE COMPOUND FOR TREATING PRECANCEROUS LEISONS | CELL PATHWAYS, INC. | 2001-03-13 | — | — | US | disclosed |
| US-5719283-A | INHIBITORS OF PHOSPHODIESTERASES; CARDIOVASCULAR DISORDERS | PFIZER INC. (US) | 1998-02-17 | — | — | US | disclosed |
| EP-0463756-B1 | Pyrazolopyrimidinone antianginal agents | PFIZER LTD (GB) | 1995-04-19 | — | — | EP | disclosed |
| US-5346901-A | Treatment of angina, hypertension, heart failure and atherosclerosis | PFIZER INC. (US) | 1994-09-13 | — | — | US | disclosed |
| US-5250534-A | Inhibitors of cyclic guanosine 3*,5*-monophosphate phosphodiesterase | PFIZER INC. (US) | 1993-10-05 | — | — | US | disclosed |
| EP-0463756-A1 | Pyrazolopyrimidinone antianginal agents | Pfizer Limited (GB) | 1992-01-02 | — | — | EP | disclosed |